Handbook Of Cancer Treatment Related Symptoms And Toxicities

Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Early recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice. Presents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. Covers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. Overviews pharmacologic and non-pharmacologic approaches to symptom management. Offers recommendations for mitigating toxicities in high-risk patients. Discusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies.

For more than 30 years, Skeel’s Handbook of Cancer Therapy (formerly Handbook of Cancer Chemotherapy) has been the resource of choice for current, reliable information on cancer treatment for most adults. The 9th Edition reflects recent significant advances in the systemic treatment of cancer, including innovations in immunotherapy, oncology genomics, and molecular targeted therapy. An invaluable reference for all levels of physicians, nurses, and allied health professionals who provide care to cancer patients, this bestselling guide combines the most current rationale and the details necessary to safely administer pharmacologic therapy, offering a balanced synthesis between science and clinical practice.

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Concisely written, yet comprehensive in scope, this new edition is a practical guide to the medical care and chemotherapeutic treatment of cancer patients. It is formatted for easy access to the more than 85 specific drugs currently used in cancer treatment. 12 illus.

An informative handbook on the staging of cancer and the selection and evaluation of cancer treatment. ESMO Handbook on Treatment Evaluation in Cancer is an ideal resource for medical oncologists and those involved in screening and chemotherapy programs. The text demonstrates how to judge various prognostic and predictive factors, how to determine the relevance of staging, and how to measure patient response for each cancer type. Written by an international team of experts, this progressive text incorporates the fast-moving world of research into the field of cancer genetics and prevention. Topics discussed include: epidemiology genetics of cancer sporadic cancers hereditary cancers primary prevention of cancer screening programmes for the general population screening programmes for those at higher risk the role of prevention secondary prevention of cancer

The incidence of cancer in senior patients has been increasing worldwide. This book reflects the state of the art in the management of senior adults with cancer. The contributors discuss epidemiology, evaluation, surgical and radiotherapy treatment, hormonal and cytotoxic treatment, and specific cancers such as lung, breast, colorectal, prostate, bladder, gynecological, and renal cell cancer. The book also examines psychological, social, and ethical aspects, as well as the role of the multidisciplinary team. Designed to help clinicians with the delicate decision-making process, it should lead to the best therapy adapted not only to the disease but also the patient.

Recognize and treat fatigue as a major symptom of cancer and cancer treatment! The Handbook of Cancer-Related Fatigue, by Dr. Roberto Patarca-Montero, the editor of the Chronic Fatigue Syndrome series from The Haworth Medical Press, focuses exclusively on fatigue as it relates to oncology. As more people every year are affected by cancer, treating the leading symptom becomes as important as treating the disease itself. Written by one of the world’s leading experts in the study of fatigue, this detailed work studies the causes, impact, and treatment of fatigue before, during, and after cancer treatment. Considered one of the most distressing yet common symptoms of cancer, fatigue must be allayed to improve the patient’s quality of life. The Handbook of Cancer-Related Fatigue studies the close relationship between fatigue and cancer, as well as cancer therapies that cause fatigue. This book identifies fatigue’s devastating effects on the body and mind and offers solutions to maximize care for all types of cancer victims using documented clinical studies from around the world. For those interested in pursuing more information, an extensive bibliography is included for all relevant text. The Handbook of Cancer-Related Fatigue provides extensive research on: determining a diagnosis of cancer-related fatigue and recognizing the syndrome at all stages of treatment long-term and short-term effects of fatigue on the cancer victim’s body and its impact on the patient’s care and treatment, even after the cancer goes into remission the underlying factors within the body systems that contribute to cancer-related fatigue numerous beneficial intervention techniques to allay the effects of cancer-related fatigue on the patient’s quality of life clinical studies showing the statistics of cancer-related fatigue in the United States and around the world identifying the relationship between cancer and fatigue using tables, references, sidebars, and an extensive bibliography and much more! Focused and thorough, The Handbook of Cancer-Related Fatigue is written for both cancer patients and health-care providers of all disciplines. Whether you are an oncologist, a therapist, or a patient, vital information is not only accessible but made easier to understand with handy charts, tables, and referenced clinical studies throughout the chapters. With fatigue categorized as one of the most important symptoms of cancer, it becomes imperative for anyone touched by this disease—personally or professionally—to keep a copy of this book at hand.

This completely revised edition continues to reflect information about the treatment of cancer, oncologic emergencies, and common clinical problems. Prepared for the nurse caring for cancer patients, there is extensive use of practical problem/intervention tables. New content, such as fatigue and spirituality, together with completely updated chapters, provide the nurse in the hospital, clinic, or home with an easy-to-use guide for dealing with complex patient problems.

Designed for quick reference, this handbook provides easily accessible information on the specific drugs and treatment regimens used in cancer chemotherapy. This updated Second Edition includes new drugs and combinations of drugs and reflects the increasing use of chemotherapy in combination with radiation and surgery. The first section presents site-specific cancer staging tables, treatment recommendations, and combination chemotherapy regimens and includes chapters on toxicity grading, dose modifications, and precautions. The second section alphabetically lists all current chemotherapeutic agents and provides essential information on each drug, including interactions, toxicity, indications, and dosing. The third section focuses on control of side effects. This edition is also available electronically for handheld computers. See Media listing for details.

Written expressly for nurses caring for patients with cancer, the 2010 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. An essential reference updated annually, the text provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2010 Oncology Nursing Drug Handbook includes: New and updated administered drugs. Specific drugs are described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations. The most important and common drug side effects are discussed.

Despite medical technological advances, the major killers with which we must currently contend have remained essentially the same for the past few decades. Stroke, cancer, and heart disease together account for the vast majority of deaths in the United States. In addition, due to improved medical care, many Americans who would previously have died now survive these disorders, necessitating that they receive appropriate rehabilitation efforts. One result of our own medical advances is that we must now accept the high costs associated with providing quality care to individuals who develop one of these problems, and we must avail ourselves to assist of afflicted individuals. families Despite the relative stability of causes of death and disability, the health-care field is currently experiencing tremendous pressures, both from professionals with in the field, who desire more and better technology than is currently available, and from the public and other payers of health care (e.g., insurance companies), who seek an end to increasing health-care costs. These pressures, along with an increased emphasis on providing evidence of cost-effectiveness and quality assurance, are substantially changing the way that health-care professionals perform their jobs.

Written especially for nurses caring for patients with cancer, the 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

Handbook of Geriatric Oncology is a practical resource for oncologists and related clinicians who want to provide comprehensive, patient-centered care to the elderly cancer patient. Divided into nine succinct sections, it includes topics spanning an Overview of Geriatric Oncology and Aging, Geriatric Syndromes, Geriatric Assessment, Select Cancers Commonly Diagnosed in the Elderly, Communication with the Older Cancer Patient, the Nursing Home Patient with Cancer, Models of Care and Survivorship, Palliative Care, and Integrative Medicine. Complex issues such as the physiologic changes of aging and their effect on cancer, corresponding social and psychological aspects that accompany aging and a cancer diagnosis, assessment of frailty, managing comorbid conditions and diseases, effective communication among healthcare providers, the patient and caregivers, as well as the risks and benefits of cancer screening, are made simpler with helpful clinical guidance and clinical pearls. Spearheaded by world experts in geriatric oncology from Memorial Sloan Kettering Cancer Center in New York, this book is the definitive resource for oncologists and related clinicians to meet the demands of clinical management along the continuum of geriatric cancer care. Key Features: Provides best practices for evaluating geriatric syndromes such as functional dependency, falls, cognitive impairment and dementia, delirium, depression and anxiety, social isolation as well as syndromes related to nutrition, comorbid conditions, and polypharmacy. Includes practical guidance on when to treat and when not to treat cancer in older patients Discusses unique factors associated with breast cancer, prostate cancer, colorectal cancer, lung cancer, ovarian cancer, bladder cancer, pancreatic cancer, head and neck cancers, and myelodysplastic syndromes in the elderly that impact care plans and treatment.

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.

In this unique handbook, the author describes his personal experience in treating cancer from three entirely different perspectives: As an expert oncologist, as a physician using complementary alternative medicine, and as a cancer victim himself. Cancer patients and professionals will find this handbook as one of the most exhaustive, definitive, and up-to-date resources of information combining complementary medicine and traditional methods for prevention and treatment of cancer. The handbook is based on Dr. Brenner’s many years of experience in treating cancer by conventional and alternative medicine, and on many articles he published in mainstream medical journals, dealing with alternative medicine and its contribution to the treatment of cancer. Various complementary and alternative treatments for different kinds of cancer are described in detail. The handbook describes the effect of food additives such as hormones, enzymes, amino acids, fatty acids and herbs on cancer; and various treatments for symptoms such as lack of appetite, diarrhea, nausea, and so on.

The Sixth Edition of this handbook is a practical, disease-focused pocket reference that emphasizes the optimal current medical practice as it relates to the delivery of chemotherapeutic drugs. In an easy-to-follow outline format, the book provides complete coverage of the basic principles of rational chemotherapy, the drugs and biologic agents available, the treatment of specific cancers, and selected aspects of supportive care. New to this edition: advances in therapies for individual cancers; significant updating of the drug information section and specific tumor types to reflect the recent development of many new agents, particularly biologic ones; and new American Cancer Society screening guidelines and cancer website information.

Updated and expanded to reflect research and clinical advances, this popular handbook provides detailed information on all facets of chemotherapy administration. It includes new chapters on targeted therapy, complementary and alternative therapies, and 100 detailed drug monographs.

Written by clinicians from the National Cancer Institute and other leading institutions, this comprehensive, clear, concise oncology handbook is designed specifically for quick bedside consultation. It covers all malignancies and offers busy clinicians practical guidelines on daily patient management, including commonly used treatment regimens and chemotherapy dosing and schedules. The user-friendly format features tables, charts, bullet points, and algorithms. The thoroughly updated Third Edition places an increased emphasis on practical clinical information, and includes new chemotherapeutic agents, dosages, and treatment regimens and the latest clinical trials data. New chapters focus on basic genomics for practicing oncologists and basic principles of radiation. The succinct yet detailed presentation is ideal for board review as well as clinical reference.

Supportive Oncology, by Drs. Davis, Feyer, Ortner, and Zimmermann, is your practical guide to improving your patients‘ quality of life and overall outcomes by integrating palliative care principles into the scope of clinical oncologic practice at all points along their illness trajectories. A multidisciplinary editorial team, representing the dual perspectives of palliative medicine and oncology, offers expert guidance on how to effectively communicate diagnoses and prognoses with cancer patients and their families, set treatment goals, and manage symptoms through pharmacological therapies, as well as non-pharmacological therapies and counselling when appropriate. Integrate complementary palliative principles as early as possible after diagnosis with guidance from a multidisciplinary editorial team whose different perspectives and collaboration provide a well-balanced approach. Effectively communicate diagnoses and prognoses with cancer patients and their families, set treatment goals, and manage symptoms through pharmacological therapies, as well as non-pharmacological therapies and counseling when appropriate. Improve patients’ quality of life with the latest information on pain and symptom management including managing side effects of chemotherapy and radiotherapy, rehabilitating and counselling long-term survivors, and managing tumor-related symptoms and other complications in the palliative care setting. Prescribe the most effective medications, manage toxicities, and deal with high symptom burdens.